Affilogic
Guillaume de Nerville is an experienced professional in the field of oncology and project management, currently serving as the International Prospecting Manager at Affilogic since September 2021. Previous experience includes a role as a business market research analyst in oncology at Sanofi Genzyme, where responsibilities involved analyzing product performance and preparing for new therapy launches. Additionally, Guillaume contributed to immuno-therapeutic research as a chercheur stagiaire at ElyssaMed SAS and Gustave Roussy. Educational qualifications include a Master of Science in Project Management from ESSEC Executive Education and multiple advanced degrees in cancer biology and health from institutions such as Université Paris-Saclay and Nantes Université.
This person is not in any teams
Affilogic
Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, including a wide range of circulating antigens (peptides, proteins), membrane receptors for inhibition / modulation (GPCR, ion channels) and complex entities (virus-like particles, bacteria, whole cells).